| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
28,830,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile OKYO Pharma is a biopharmaceutical company. Co. is engaged in developing next-generation therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain using G protein-coupled receptors. G protein-coupled receptors is the family of membrane proteins involved in many biological processes and proven to be an approach for treatment of a range of conditions including cardiovascular disease, cancer and diabetes.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
7,500,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$834,238 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
5 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Cerrone Gabriel M |
Executive Chairman |
• • – |
2023-10-27 |
4 |
A |
$1.50 |
$105,107 |
I/I |
70,071 |
9,177,903 |
|
- |
|
| Cerrone Gabriel M |
Executive Chairman |
• • – |
2023-10-23 |
4 |
A |
$1.50 |
$749,202 |
I/I |
499,468 |
9,107,832 |
|
- |
|
| Cerrone Gabriel M |
Executive Chairman |
• • – |
2022-05-19 |
4 |
B |
$0.08 |
$440,800 |
I/I |
5,800,000 |
548,981,215 |
2.66 |
- |
|
| Cerrone Gabriel M |
Non-Executive Chairman |
• • • |
2022-05-19 |
4 |
B |
$4.00 |
$150,000 |
I/I |
37,500 |
62,500 |
2.64 |
- |
|
| Jacob Gary S |
Chief Executive Officer |
• • – |
2022-05-19 |
4 |
B |
$4.00 |
$50,000 |
D/D |
12,500 |
12,500 |
2.81 |
- |
|
| Cerrone Gabriel M |
Non-Executive Chairman |
• • • |
2022-05-17 |
4/A |
B |
$3.87 |
$96,750 |
I/I |
25,000 |
25,000 |
2.64 |
- |
|
| Cerrone Gabriel M |
Non-Executive Chairman |
• • • |
2022-05-17 |
4 |
B |
$0.06 |
$96,688 |
I/I |
1,625,000 |
544,806,215 |
2.64 |
- |
|
| Cerrone Gabriel M |
Executive ChairmanOfficer |
• • • |
2022-05-16 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
543,181,215 |
|
- |
|
8 Records found
|
1
|
Page 1 of 1 |
|
|
